CCSC

National Hemophilia Foundation

Website provided by National Hemophilia Foundation and its education partners

CCSC Presentation at the 70th NHF Bleeding Disorders Conference

CCSC Presents: Future of 340B and Sustainability of the HTC 
Saturday, October 13, 2018 
1:00 pm-3:15 pm 
Orlando World Center Marriott 
Orlando, FL 
Room: Grand Ballroom 8A

Click here to download this presentation.

***Sign up to become a member and receive updates, access to useful resources, and practice tools.*** 

  Become a Member

Program Overview

Amidst controversy surrounding attempts to repeal and replace the Affordable Care Act (ACA), increasing financial pressures appear to be a mainstay in the US health care system. Rising specialty drug spend-coupled with more stringent payer management efforts in terms of contracting, utilization management, patient cost share coupled with uncertainty surrounding the 340B program and flat federal funding have created a challenging environment for HTCs. CCSC provides a unique forum for HTC clinicians to collaborate with payers in order to facilitate the sustainability of the HTC care model.

Who Should Attend

  • Hemophilia Treatment Center Providers and Administrators
  • Managed Care and Other Payer Professionals involved in the management of patients with hemophilia

Agenda

1:00 PM Lunch and Registration
1:05 PM

Opening Comments and Objectives
Edmund Pezalla, MD, MPH
CEO
Enlightenment Bioconsult, LLC
1:10 PM 340B Update: The Current Environment and Potential Impact for Hemophilia Treatment Centers 
Johanna Gray 
Senior Vice President
CRD Associates
1:35 PM Health Care Transformation and the HTC Model: Positioning for Success 
Marisela Trujillo, MSW
Administrative Director
University of Texas Health Gulf States Hemophilia and Thrombophilia Center
2:00 PM Payer Perspectives and Collaborative Opportunities for the Management of Bleeding Disorders
Edmund Pezalla, MD, MPH
2:25 PM CCSC: Charting a Course for Cost-effective, Improved Outcomes in Hemophilia Management
Kollet Koulianos, MBA
Senior Director Payer Relations
National Hemophilia Foundation
3:00 PM Panel Discussion and Audience Q&A 
3:15 PM Adjourn

Expert Panel

Johanna Gray 
Senior Vice President
CRD Associates		 Kollet Koulianos, MBA
Senior Director Payer Relations
National Hemophilia Foundation
Edmund Pezalla, MD, MPH
CEO
Enlightenment Bioconsult, LLC		 Marisela Trujillo, MSW
Administrative Director
University of Texas Health Gulf States Hemophilia and Thrombophilia Center

 

 

Jointly provided by

Jointly provided by

    

  • CCSC is supported by charitable donations from founding supporter Takeda, and additional support from BioMarin, Biotechnology Innovation Organization, Bleeding & Clotting Disorders Institute, CSL Behring, Genentech, Inc., Gulf States Hemophilia and Thrombophilia Center, Louisiana Center for Bleeding and Clotting Disorders, Sanofi, and Spark Therapeutics.

  • Copay Accumulator Adjustment Program (CAAP) Outreach is supported by AbbVie, Inc.

    © 2023 National Hemophilia Foundation. All rights reserved.

 

Footer Menu